| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 406.721.898 $ | +161.753.611 $ | +54,9 % | 9 | 291.299.161 $ | +75.096.639 $ | +34,1 % | 8 | 240.589.561 $ | +115.828.473 $ | +116,1 % | 8 | ||||
| CG Oncology, Inc. | CGON | → 0 | Neutral | 150.349.360 $ | +58.113.760 $ | +63,0 % | 1 | 92.235.600 $ | +2.754.627 $ | +3,1 % | 1 | 89.480.973 $ | +31.722.649 $ | +54,9 % | 1 |
| ALUMIS INC. | ALMS | → 0 | Neutral | 93.576.170 $ | +52.118.911 $ | +125,7 % | 1 | 41.457.259 $ | +24.509.056 $ | +144,6 % | 1 | 16.948.203 $ | +4.205.193 $ | +33,0 % | 1 |
| Centessa Pharmaceuticals plc | CNTA | → 0 | 54.178.835 $ | +20.064.720 $ | +58,8 % | 1 | 34.114.115 $ | +2.249.154 $ | +7,1 % | 1 | 31.864.961 $ | +15.395.561 $ | +93,5 % | 1 | |
| RAPT Therapeutics, Inc. | RAPT | → 0 | 52.921.875 $ | +12.625.000 $ | +31,3 % | 1 | 40.296.875 $ | +27.796.875 $ | +222,4 % | 1 | |||||
| Corvus Pharmaceuticals, Inc. | CRVS | → 0 | Neutral | 26.790.939 $ | +16.155.445 $ | +151,9 % | 1 | 12.759.187 $ | +5.834.255 $ | +84,2 % | 1 | ||||
| Verastem, Inc. | VSTM | → 0 | Neutral | 16.677.144 $ | -7.525.982 $ | -31,1 % | 1 | 24.203.126 $ | +1.111.616 $ | +4,8 % | 1 | 23.091.510 $ | +17.793.952 $ | +335,9 % | 1 |
| Denali Therapeutics Inc. | DNLI | → 0 | Neutral | 23.231.443 $ | +6.721.443 $ | +40,7 % | 1 | 16.510.000 $ | +1.990.000 $ | +13,7 % | 1 | 14.520.000 $ | +14.520.000 $ | 1 | |
| AGIOS PHARMACEUTICALS, INC. | AGIO | → 0 | Neutral | 17.760.750 $ | +3.334.150 $ | +23,1 % | 1 | 14.426.600 $ | +14.426.600 $ | 1 | |||||
| Natera, Inc. | NTRA | → 0 | Neutral | 15.430.586 $ | +15.430.586 $ | 1 | |||||||||
| Kymera Therapeutics, Inc. | KYMR | → 0 | Schwach | 12.187.992 $ | +801.899 $ | +7,0 % | 1 | ||||||||
| Minerva Neurosciences, Inc. | NERV | → 0 | Neutral | 11.969.265 $ | +11.969.265 $ | 1 | |||||||||
| Akero Therapeutics, Inc. | → 0 | 11.627.852 $ | -1.440.012 $ | -11,0 % | 1 | ||||||||||
| 406.721.898 $ | +161.753.611 $ | +54,9 % | 9 | 291.299.161 $ | +75.096.639 $ | +34,1 % | 8 | 240.589.561 $ | +115.828.473 $ | +116,1 % | 8 | ||||